Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,870 | 143 | 92.5% |
| Consulting Fee | $225.00 | 1 | 7.3% |
| Education | $6.65 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $369.21 | 17 | $0 (2024) |
| ABBVIE INC. | $349.38 | 18 | $0 (2024) |
| PFIZER INC. | $348.38 | 18 | $0 (2024) |
| Lilly USA, LLC | $277.20 | 14 | $0 (2024) |
| Becton, Dickinson and Company | $225.00 | 1 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $216.03 | 12 | $0 (2024) |
| GlaxoSmithKline, LLC. | $206.78 | 12 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $144.96 | 6 | $0 (2024) |
| Abbott Laboratories | $106.19 | 5 | $0 (2024) |
| Astellas Pharma US Inc | $102.75 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,662 | 84 | Novo Nordisk Inc ($239.93) |
| 2023 | $840.80 | 39 | AbbVie Inc. ($163.29) |
| 2022 | $225.00 | 1 | Becton, Dickinson and Company ($225.00) |
| 2021 | $23.22 | 1 | AbbVie Inc. ($23.22) |
| 2020 | $35.19 | 2 | Allergan, Inc. ($20.29) |
| 2019 | $103.27 | 5 | Abbott Laboratories ($24.02) |
| 2018 | $164.86 | 10 | Janssen Pharmaceuticals, Inc ($37.83) |
| 2017 | $46.87 | 3 | Janssen Pharmaceuticals, Inc ($18.75) |
All Payment Transactions
145 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.00 | General |
| Category: Diabetes | ||||||
| 12/11/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $19.28 | General |
| Category: Diabetes | ||||||
| 12/09/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.26 | General |
| Category: RESPIRATORY | ||||||
| 12/05/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $19.20 | General |
| Category: Oncology | ||||||
| 11/27/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $22.25 | General |
| Category: Gastroenterology | ||||||
| 11/25/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $19.53 | General |
| Category: PAIN | ||||||
| 11/20/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $17.93 | General |
| Category: Diabetes Care | ||||||
| 11/18/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $16.22 | General |
| Category: Obesity | ||||||
| 11/13/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $21.91 | General |
| Category: Diabetes | ||||||
| 11/11/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.54 | General |
| Category: RESPIRATORY | ||||||
| 11/04/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $15.85 | General |
| Category: PSYCHIATRY | ||||||
| 10/29/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $28.07 | General |
| Category: Diabetes | ||||||
| 10/21/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $19.48 | General |
| Category: Obesity | ||||||
| 10/17/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $20.45 | General |
| Category: VACCINE | ||||||
| 10/11/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $25.38 | General |
| Category: Inflammation | ||||||
| 10/07/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $18.99 | General |
| Category: Diabetes | ||||||
| 10/03/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $24.25 | General |
| Category: PAIN | ||||||
| 10/01/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.95 | General |
| Category: RESPIRATORY | ||||||
| 09/25/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), XIFAXAN | Food and Beverage | In-kind items and services | $18.51 | General |
| Category: Gastroenterology | ||||||
| 09/23/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $32.38 | General |
| Category: Biological | ||||||
| 09/16/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $26.96 | General |
| Category: NEUROSCIENCE | ||||||
| 09/13/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $22.69 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 09/10/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $29.59 | General |
| Category: Obesity | ||||||
| 09/05/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $17.07 | General |
| Category: NEUROSCIENCE | ||||||
| 09/03/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $29.03 | General |
| Category: PAIN | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 1,615 | 2,144 | $405,140 | $147,221 |
| 2022 | 13 | 1,301 | 1,898 | $215,522 | $119,434 |
| 2021 | 12 | 1,366 | 2,085 | $213,384 | $136,961 |
| 2020 | 12 | 1,491 | 2,146 | $207,925 | $107,712 |
All Medicare Procedures & Services
52 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 368 | 666 | $194,472 | $63,517 | 32.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 260 | 260 | $77,480 | $34,133 | 44.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 221 | 282 | $58,092 | $19,063 | 32.8% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 108 | 108 | $40,608 | $18,106 | 44.6% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 350 | 512 | $8,382 | $3,075 | 36.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 24 | 24 | $9,024 | $2,727 | 30.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 58 | 59 | $7,552 | $2,484 | 32.9% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 18 | 18 | $3,726 | $1,319 | 35.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 34 | 34 | $1,700 | $1,067 | 62.7% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 26 | 26 | $1,300 | $815.62 | 62.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 43 | 44 | $1,496 | $493.92 | 33.0% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Office | 2023 | 22 | 24 | $401.00 | $148.80 | 37.1% |
| 96127 | Assessment of emotional or behavioral problems | Office | 2023 | 45 | 47 | $564.00 | $146.30 | 25.9% |
| 93005 | Routine electrocardiogram (ecg) using at least 12 leads with tracing | Office | 2023 | 13 | 13 | $208.00 | $67.99 | 32.7% |
| 81003 | Automated urinalysis test | Office | 2023 | 25 | 27 | $135.00 | $57.20 | 42.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 470 | 790 | $126,751 | $72,005 | 56.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 247 | 389 | $45,390 | $25,786 | 56.8% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 27 | 27 | $9,450 | $6,274 | 66.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 45 | 45 | $11,040 | $4,574 | 41.4% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 40 | 42 | $4,695 | $3,553 | 75.7% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2022 | 326 | 454 | $7,718 | $2,946 | 38.2% |
| 99495 | Transitional care management services for problem of moderate complexity | Office | 2022 | 16 | 17 | $3,825 | $2,823 | 73.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 70 | 71 | $3,821 | $639.71 | 16.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 16 | 16 | $662.00 | $465.40 | 70.3% |
| 93225 | Electrocardiogram (ecg) 2-day continuous | Office | 2022 | 11 | 11 | $1,166 | $142.27 | 12.2% |
About Dr. Nitin Damle, MD
Dr. Nitin Damle, MD is a Internal Medicine healthcare provider based in Wakefield, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1457399388.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Nitin Damle, MD has received a total of $3,102 in payments from pharmaceutical and medical device companies, with $1,662 received in 2024. These payments were reported across 145 transactions from 29 companies. The most common payment nature is "Food and Beverage" ($2,870).
As a Medicare-enrolled provider, Damle has provided services to 5,773 Medicare beneficiaries, totaling 8,273 services with total Medicare billing of $511,328. Data is available for 4 years (2020–2023), covering 52 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Wakefield, RI
- Active Since 06/03/2006
- Last Updated 06/25/2010
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1457399388
Products in Payments
- MOUNJARO (Drug) $221.48
- UBRELVY (Drug) $218.42
- TRELEGY ELLIPTA (Drug) $190.64
- Wegovy (Drug) $152.04
- QULIPTA (Drug) $151.25
- ELIQUIS (Drug) $149.56
- Ozempic (Drug) $136.62
- NURTEC ODT (Drug) $116.39
- Veozah (Drug) $102.75
- XIFAXAN (Drug) $98.59
- TRADJENTA (Drug) $91.87
- Cologuard Collection Kit (Device) $87.10
- FARXIGA (Drug) $83.06
- FREESTYLE LIBRE 3 (Device) $82.17
- BREZTRI (Drug) $81.81
- GARDASIL (Biological) $56.87
- PAXLOVID (Drug) $54.79
- OFEV (Drug) $53.09
- JARDIANCE (Drug) $49.07
- Rybelsus (Drug) $42.65
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Wakefield
Dr. Bruce Watrous, M.d, M.D
Internal Medicine — Payments: $9,530
Dr. James Rocco, M.d, M.D
Internal Medicine — Payments: $6,711
Monique Pouliot, D.o, D.O
Internal Medicine — Payments: $3,120
Heidi Dorris, M.d, M.D
Internal Medicine — Payments: $3,009
Paul Barratt, M.d, M.D
Internal Medicine — Payments: $2,857
Dr. Griffin Reynolds, Md, MD
Internal Medicine — Payments: $2,808